R. Chen

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Mauricio Jadzinsky, Andreas Pfützner, Elizabeth Paz-Pacheco et al. · Diabetes Obesity and Metabolism · 2009 · 293 citations · Full text

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

Antônio Roberto Chacra, G. H. Tan, Anne Marie Apanovitch et al. · International Journal of Clinical Practice · 2009 · 237 citations · Full text

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Andreas Pfützner, Elizabeth Paz-Pacheco, Elsie Allen et al. · Diabetes Obesity and Metabolism · 2011 · 91 citations

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA

Andrew Palmer, Valentine Wn, R. Chen et al. · Nephrology Dialysis Transplantation · 2007 · 85 citations